Isolation and Characterisation of Human Adipose-Derived Stem Cells.

ASCs Adipose stem cells Adipose-derived stem cells Characterization Collagenase Immunomodulation Immunosuppression Isolation Lipoaspirate Lipotransfer Stromal vascular fraction

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 17 1 2019
pubmed: 17 1 2019
medline: 14 6 2019
Statut: ppublish

Résumé

Recently, adipose-derived stem cells (ASCs), obtained from fresh human lipoaspirate, have shown promise as immunomodulatory agents having demonstrated immunosuppressive functionality both in vitro and in vivo. A number of researchers have described the isolation of ASCs through the enzymatic digestion of fat samples, followed by a number of purification steps, involving centrifugation and filtration. Here, we utilize a standard isolation technique, with the added purification of putative ASCs by fluorescence activated cell sorting (FACS). ASCs are an extremely valuable resource in clinical applications, including reconstruction, regeneration, and investigations into immune activity. This method could be used to isolate and purify ASCs for such downstream applications.

Identifiants

pubmed: 30649761
doi: 10.1007/978-1-4939-8938-6_1
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-13

Auteurs

Anna Wilson (A)

Research Department of Surgical Biotechnology, UCL Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, UK.

Melisse Chee (M)

Research Department of Surgical Biotechnology, UCL Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, UK.

Peter Butler (P)

Research Department of Surgical Biotechnology, UCL Division of Surgery and Interventional Science, University College London, Royal Free Hospital, London, UK.

Ashleigh S Boyd (AS)

Associate Professor in Stem Cell Biology and Regenerative Medicine, Research Department of Surgical Biotechnology Division of Surgery and Interventional Science University College London (UCL), Royal Free Hospital, London, UK. a.boyd@ucl.ac.uk.
UCL Institute of Immunity and Transplantation, Royal Free Hospital, London, UK. a.boyd@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH